![Uwe Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uwe Klein
Corporate Officer/Principal at
SEPTERNA, INC.
Net worth: 4 M $ as of 30/07/2026
Profile
Uwe Klein currently works at Septerna, Inc., as Senior Vice President-Biological Sciences from 2021.
Dr. Klein also formerly worked at Theravance Biopharma, Inc., as Senior Director-Molecular & Cellular Biology from 1998 to 2014, Bristol Myers Squibb Co., as Vice President-Biology from 2020 to 2021, MyoKardia, Inc., as Vice President-Biology from 2019 to 2020, and Numerate, Inc., as Vice President-Biology from 2014 to 2019.
Dr. Klein received his undergraduate degree, graduate degree, and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SEPTERNA, INC. 0.28% | 05/02/2026 | 127,533 ( 0.28% ) | 4 M $ | 30/07/2026 |
Uwe Klein active positions
| Companies | Position | Start |
|---|---|---|
| SEPTERNA, INC. | Corporate Officer/Principal | 31/07/2021 |
Former positions of Uwe Klein
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 28/02/2021 |
| MYOKARDIA, INC. | Corporate Officer/Principal | 31/10/2020 |
Numerate, Inc.
 Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Corporate Officer/Principal | 31/08/2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 30/09/2014 |
Training of Uwe Klein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Numerate, Inc.
Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Technology Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
- Stock Market
- Insiders
- Uwe Klein
